GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aethlon Medical Inc (FRA:EJU0) » Definitions » Earnings per Share (Diluted)

Aethlon Medical (FRA:EJU0) Earnings per Share (Diluted) : €-3.55 (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aethlon Medical Earnings per Share (Diluted)?

Aethlon Medical's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was €-0.32. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.55.

Aethlon Medical's EPS (Basic) for the three months ended in Jun. 2024 was €-0.32. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.55.

Aethlon Medical's EPS without NRI for the three months ended in Jun. 2024 was €-0.32. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was €-3.55.

During the past 3 years, the average EPS without NRIGrowth Rate was 9.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 34.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 32.50% per year.

During the past 13 years, Aethlon Medical's highest 3-Year average EPS without NRI Growth Rate was 53.10% per year. The lowest was -848.90% per year. And the median was 15.50% per year.


Aethlon Medical Earnings per Share (Diluted) Historical Data

The historical data trend for Aethlon Medical's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aethlon Medical Earnings per Share (Diluted) Chart

Aethlon Medical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.92 -5.46 -6.45 -5.47 -4.47

Aethlon Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.25 -1.14 -1.26 -0.84 -0.32

Competitive Comparison of Aethlon Medical's Earnings per Share (Diluted)

For the Medical Devices subindustry, Aethlon Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aethlon Medical's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's PE Ratio distribution charts can be found below:

* The bar in red indicates where Aethlon Medical's PE Ratio falls into.



Aethlon Medical Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Aethlon Medical's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-11.231-0)/2.513
=-4.47

Aethlon Medical's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-2.388-0)/7.458
=-0.32

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Aethlon Medical  (FRA:EJU0) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Aethlon Medical Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Aethlon Medical's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aethlon Medical Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical Headlines

No Headlines